Monitor next quarter's earnings for continued international growth trends and margin stabilization, as the current margin compression from international expansion and new production costs could reverse as economies of scale are achieved.
Price Chart
Executive Summary
Vycor Medical reported annual financial results for 2025, showing 17% revenue growth to $1.86 million and a return to profitability with $33,900 in operating profit compared to a $9,145 loss in 2024. The company highlighted 18% growth in its core Vycor Medical division, driven by international expansion.
Key Financial Metrics
Key Facts
- Revenue for 2025 was $1,863,400, a 17% increase from $1,589,324 in 2024
- Vycor Medical division revenue grew 18% to $1,796,070, with most growth from international markets
- Company returned to operating profit of $33,900 in 2025 vs $9,145 operating loss in 2024
- Gross profit margin decreased to 83% from 89% due to higher production and international sales costs
- NovaVision division revenue decreased 8% to $67,330 for the year
Financial Impact
Revenue increased by $274,076 (17%) with operating profit improvement of $43,045
Risk Factors
- Gross margin declined from 89% to 83% due to higher production and international sales costs
- NovaVision division revenue declined 8% year-over-year
- Company continues to report net losses despite operating profit improvement
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-014079 |
| Document: form8-k.htm | 0001493152-26-014079 |
| Document: 0001493152-26-014079-index-headers.html | 0001493152-26-014079 |
| Document: 0001493152-26-014079-index.html | 0001493152-26-014079 |
| Document: 0001493152-26-014079.txt | 0001493152-26-014079 |
| 8-K Data (Synthetic) | 0001493152-26-014079 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 8-K | $0.0690 $0.0670 | ▲ +2.90% | ▲ +1.37% | $0.0260 (+62.32%) |
May 15, 2026 23w ago | 8-K | $0.0700 $0.0700 | · 0.00% | ▼ −2.12% | $0.0260 (−62.86%) |
Mar 31, 2026 30w ago | 8-K | $0.0900 $0.0690 | ▼ −23.33% | ▼ −32.76% | $0.0260 (−71.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers